| 1 | Leukemia P388 | 52.5% |
| 2 | Carcinoma, Ehrlich Tumor | 26.7% |
| 3 | Carcinoma, Lewis Lung | 26.7% |
| 4 | Carcinoma 256, Walker | 25.7% |
| 5 | Neoplasms, Germ Cell and Embryonal | 23.6% |
| 6 | Neoplasms, Glandular and Epithelial | 23.6% |
| 7 | Germ Cell Cancer | 23.6% |
| 8 | Hamartoma | 22.4% |
| 9 | Neoplasms, Hormone-Dependent | 22.4% |
| 10 | Neoplasms, Multiple Primary | 22.4% |
| 11 | Paraneoplastic Syndromes | 22.4% |
| 12 | Precancerous Conditions | 22.4% |
| 13 | Neoplasms, Second Primary | 22.4% |
| 14 | Leukemia, Plasma Cell | 22.2% |
| 15 | Neuroectodermal Tumors | 21.5% |
| 16 | Sarcoma, Experimental | 21.2% |
| 17 | Sarcoma, Myeloid | 21.1% |
| 18 | Melanoma, Experimental | 20.5% |
| 19 | Neoplasms, Neuroepithelial | 20.3% |
| 20 | Gliomatosis cerebri | 20.3% |
| 21 | Leukemia, Radiation-Induced | 20.2% |
| 22 | Mammary Neoplasms, Experimental | 20% |
| 23 | Carcinosarcoma | 18% |
| 24 | Hemangiosarcoma | 18% |
| 25 | lymphangiosarcoma | 18% |
| 26 | Sarcoma 180 | 18% |
| 27 | Histiocytic Disorders, Malignant | 17.6% |
| 28 | melanoma | 17.5% |
| 29 | Cyst | 16.8% |
| 30 | Neoplastic Processes | 16.8% |
| 31 | Neoplastic Syndromes, Hereditary | 16.8% |
| 32 | Pregnancy Complications, Neoplastic | 16.8% |
| 33 | Dermoid Cyst | 16.7% |
| 34 | Meningioma | 16.3% |
| 35 | Trophoblastic Neoplasms | 16.1% |
| 36 | Medulloblastoma | 15.1% |
| 37 | Adenoma, Acidophil | 14.8% |
| 38 | Ganglioneuroma | 14.8% |
| 39 | Glioma | 14.8% |
| 40 | Malignant Glioma | 14.8% |
| 41 | Basal cell carcinoma | 14.6% |
| 42 | Carcinoma, Papillary | 14.6% |
| 43 | Squamous cell carcinoma | 14.6% |
| 44 | Chondrosarcoma | 14.6% |
| 45 | Craniopharyngioma | 14.6% |
| 46 | Cystadenoma | 14.6% |
| 47 | leiomyosarcoma | 14.6% |
| 48 | liposarcoma | 14.6% |
| 49 | Mesothelioma | 14.6% |
| 50 | synovial sarcoma | 14.6% |
| 51 | Neuroectodermal Tumor, Melanotic | 14.6% |
| 52 | Angiomyolipoma | 14.6% |
| 53 | Clear Cell Sarcoma of Soft Tissue | 14.6% |
| 54 | Alveolar Soft Part Sarcoma | 14.6% |
| 55 | Neuroendocrine Tumors | 14.6% |
| 56 | Carcinoma, Basal Cell | 14.6% |
| 57 | Adenoma | 14.3% |
| 58 | Ameloblastoma | 14.3% |
| 59 | Angiokeratoma | 14.3% |
| 60 | Carcinoma | 14.3% |
| 61 | Chordoma | 14.3% |
| 62 | Hemangioma | 14.3% |
| 63 | hemangiopericytoma | 14.3% |
| 64 | Lymphangioma | 14.3% |
| 65 | Mesenchymoma | 14.3% |
| 66 | Nevus | 14.3% |
| 67 | Teratoma | 14.3% |
| 68 | Hepatoblastoma | 14.3% |
| 69 | Mixed Tumor, Mullerian | 14.3% |
| 70 | Germinoma | 14.3% |
| 71 | Teratocarcinoma | 14.3% |
| 72 | Angiofibroma | 14.3% |
| 73 | Sarcoma | 14.3% |
| 74 | Epithelioma | 14.3% |
| 75 | Composite Lymphoma | 14.2% |
| 76 | Multiple Endocrine Neoplasia | 14.1% |
| 77 | Lymphoma | 14.1% |
| 78 | Leukemia, Myelomonocytic, Chronic | 13.8% |
| 79 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 13.8% |
| 80 | Carcinoid Tumor | 13.5% |
| 81 | Neurilemmoma | 13.5% |
| 82 | Hutchinson's Melanotic Freckle | 13.5% |
| 83 | Melanoma, Amelanotic | 13.5% |
| 84 | Liver Neoplasms, Experimental | 13.3% |
| 85 | Neoplasms, Radiation-Induced | 13.2% |
| 86 | Acanthoma | 13.1% |
| 87 | Cystadenocarcinoma | 13% |
| 88 | Fibrosarcoma | 13% |
| 89 | Osteosarcoma | 13% |
| 90 | Mucoepidermoid Carcinoma | 13% |
| 91 | Choriocarcinoma | 12.5% |
| 92 | Carcinoma, Lobular | 12.5% |
| 93 | Abdominal Neoplasms | 12.4% |
| 94 | Erythroplasia | 12.4% |
| 95 | Follicular cyst | 12.4% |
| 96 | Head and Neck Neoplasms | 12.4% |
| 97 | Mucocele | 12.4% |
| 98 | Pilonidal Cyst | 12.4% |
| 99 | Soft Tissue Neoplasms | 12.4% |
| 100 | Thoracic Neoplasms | 12.4% |
| 101 | Thyroglossal Cyst | 12.4% |
| 102 | Synovial Cyst | 12.4% |
| 103 | Aberrant Crypt Foci | 12.4% |
| 104 | Paraneoplastic Encephalomyelitis | 12.2% |
| 105 | Astrocytoma | 12.2% |
| 106 | Ependymoma | 12.2% |
| 107 | oligodendroglioma | 12.2% |
| 108 | Ganglioglioma | 12.2% |
| 109 | gliosarcoma | 12.2% |
| 110 | Anaplastic astrocytoma | 12.2% |
| 111 | Anaplastic Oligodendroglioma | 12.2% |
| 112 | Adenofibroma | 12.1% |
| 113 | Fibroadenoma | 12.1% |
| 114 | Malignant Fibrous Histiocytoma | 12.1% |
| 115 | Thymoma | 11.8% |
| 116 | Malignant Carcinoid Syndrome | 11.5% |
| 117 | Bowen's Disease | 11.3% |
| 118 | Paraganglioma | 11.3% |
| 119 | Rhabdomyosarcoma | 11.3% |
| 120 | Giant Cell Tumor of Bone | 11.3% |
| 121 | Leukemia, T-Cell | 11% |
| 122 | Leukemia, B-Cell | 11% |
| 123 | Glioblastoma | 10.9% |
| 124 | Neuroblastoma | 10.9% |
| 125 | Glioblastoma Multiforme | 10.9% |
| 126 | Plasmacytoma | 10.7% |
| 127 | Endometrial Stromal Sarcoma | 10.7% |
| 128 | Malignant histiocytosis | 10.7% |
| 129 | Histiocytic sarcoma | 10.7% |
| 130 | Leukemia, Myeloid, Chronic-Phase | 10.5% |
| 131 | Dermatofibrosarcoma | 10.5% |
| 132 | Dermatofibrosarcoma Protuberans | 10.5% |
| 133 | Retinoblastoma | 10.2% |
| 134 | Ganglioneuroblastoma | 10.2% |
| 135 | Tuberous Sclerosis | 10.1% |
| 136 | Adenocarcinoma | 9.8% |
| 137 | Carcinoma in Situ | 9.8% |
| 138 | Carcinoma, Transitional Cell | 9.8% |
| 139 | Phyllodes Tumor | 9.8% |
| 140 | Dysgerminoma | 9.8% |
| 141 | Hemangioendothelioma | 9.8% |
| 142 | Lipoma | 9.8% |
| 143 | Lymphomatoid Granulomatosis | 9.8% |
| 144 | Myoma | 9.8% |
| 145 | Myxoma | 9.8% |
| 146 | Neuroma | 9.8% |
| 147 | Papilloma | 9.8% |
| 148 | Pseudomyxoma Peritonei | 9.8% |
| 149 | Seminoma | 9.8% |
| 150 | Papillomatosis | 9.8% |
| 151 | Angiolipoma | 9.8% |
| 152 | Myelolipoma | 9.8% |
| 153 | Neoplasms, Bone Tissue | 9.8% |
| 154 | Neoplasms, Fibrous Tissue | 9.8% |
| 155 | Smooth Muscle Tumor | 9.8% |
| 156 | Adenomatosis, Pulmonary | 9.8% |
| 157 | Adenomatous Polyps | 9.8% |
| 158 | Carcinoma, Large Cell | 9.8% |
| 159 | Carcinoma, Small Cell | 9.8% |
| 160 | Desmoplastic Small Round Cell Tumor | 9.8% |
| 161 | Chondroma | 9.8% |
| 162 | Enchondroma | 9.8% |
| 163 | Digestive System Neoplasms | 9.7% |
| 164 | Endocrine Gland Neoplasms | 9.7% |
| 165 | Eye Neoplasms | 9.7% |
| 166 | Nervous System Neoplasms | 9.7% |
| 167 | Lymphangioleiomyomatosis | 9.7% |
| 168 | Pheochromocytoma | 9.6% |
| 169 | Alveolar rhabdomyosarcoma | 9.6% |
| 170 | Bone neoplasms | 9.4% |
| 171 | Leukoplakia | 9.4% |
| 172 | Lymphocele | 9.4% |
| 173 | Pancreatic Cyst | 9.4% |
| 174 | Skin Neoplasms | 9.4% |
| 175 | Hematologic Neoplasms | 9.4% |
| 176 | Barrett Esophagus | 9.2% |
| 177 | Breast Cyst | 9.2% |
| 178 | Actinic keratosis | 9.2% |
| 179 | Mediastinal Cyst | 9.2% |
| 180 | Neoplasm Invasiveness | 9.2% |
| 181 | Neoplasm Metastasis | 9.2% |
| 182 | Neoplasm Recurrence, Local | 9.2% |
| 183 | Parovarian Cyst | 9.2% |
| 184 | Pericardial Cyst | 9.2% |
| 185 | Splenic Neoplasms | 9.2% |
| 186 | Thymic Cyst | 9.2% |
| 187 | Carcinogenesis | 9.2% |
| 188 | Myxoid cyst | 9.2% |
| 189 | Metastasis | 9.2% |
| 190 | Nephroblastoma | 9.2% |
| 191 | Neurofibrosarcoma | 9.1% |
| 192 | Carcinoid Heart Disease | 8.9% |
| 193 | Multiple Endocrine Neoplasia Type 1 | 8.9% |
| 194 | Basal Cell Nevus Syndrome | 8.6% |
| 195 | Hodgkin Disease | 8.5% |
| 196 | Lymphoma, Non-Hodgkin | 8.5% |
| 197 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 8.4% |
| 198 | Leukemia, Large Granular Lymphocytic | 8.4% |
| 199 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 8.4% |
| 200 | Carcinoma, Pancreatic Ductal | 8.3% |
| 201 | Acoustic Neuroma | 8% |
| 202 | Parathyroid Neoplasms | 7.9% |
| 203 | Peritoneal Neoplasms | 7.9% |
| 204 | Thyroid Neoplasm | 7.9% |
| 205 | Thyroid carcinoma | 7.9% |
| 206 | Neoplasms, Experimental | 7.8% |
| 207 | Hydatidiform Mole | 7.7% |
| 208 | Retroperitoneal Neoplasms | 7.7% |
| 209 | Hepatocellular Adenoma | 7.7% |
| 210 | Adenoid Cystic Carcinoma | 7.6% |
| 211 | fibroma | 7.6% |
| 212 | Fibromatosis | 7.6% |
| 213 | Osteoblastoma | 7.6% |
| 214 | Osteoma | 7.6% |
| 215 | Rhabdomyoma | 7.6% |
| 216 | Chondromatosis | 7.6% |
| 217 | Adenocarcinoma, Clear Cell | 7.6% |
| 218 | Cholangiocarcinoma | 7.6% |
| 219 | Cervical Intraepithelial Neoplasia | 7.6% |
| 220 | Hemangioblastoma | 7.6% |
| 221 | Lymphoma, Extranodal NK-T-Cell | 7.6% |
| 222 | Corpus Luteum Cyst | 7.3% |
| 223 | Ovarian Cysts | 7.3% |
| 224 | Primary amyloidosis | 7.1% |
| 225 | Vipoma | 7.1% |
| 226 | Optic Nerve Glioma | 7.1% |
| 227 | Mesoblastic Nephroma | 6.9% |
| 228 | Pancreatic Neoplasm | 6.8% |
| 229 | leukemia | 6.7% |
| 230 | Tracheal Neoplasms | 6.7% |
| 231 | Leukoplakia, Oral | 6.6% |
| 232 | Paraneoplastic Cerebellar Degeneration | 6.6% |
| 233 | Prolactinoma | 6.5% |
| 234 | Growth Hormone-Secreting Pituitary Adenoma | 6.5% |
| 235 | Fibromatosis, Aggressive | 6.5% |
| 236 | Fibromatosis, Abdominal | 6.5% |
| 237 | Klatskin Tumor | 6.5% |
| 238 | Adenomatous Polyposis Coli | 6.3% |
| 239 | Choledochal Cyst | 6.2% |
| 240 | Peutz-Jeghers Syndrome | 6.1% |
| 241 | insulinoma | 6% |
| 242 | Leukemia, Experimental | 6% |
| 243 | Mastocytosis | 6% |
| 244 | Sturge-Weber Syndrome | 6% |
| 245 | Gastrointestinal Stromal Tumors | 5.9% |
| 246 | Hemangioma, Cavernous | 5.9% |
| 247 | Mouth Neoplasms | 5.9% |
| 248 | Central Nervous System Neoplasms | 5.9% |
| 249 | Vascular Neoplasms | 5.9% |
| 250 | Thymus Neoplasms | 5.9% |
| 251 | neurofibroma | 5.8% |
| 252 | Lymphoma, Follicular | 5.8% |
| 253 | T-Cell Lymphoma | 5.8% |
| 254 | Mantle cell lymphoma | 5.8% |
| 255 | Genital Neoplasms, Female | 5.8% |
| 256 | Pancreatic Pseudocyst | 5.8% |
| 257 | Lymphatic Metastasis | 5.7% |
| 258 | Neoplasms, Unknown Primary | 5.7% |
| 259 | Leukemic Infiltration | 5.7% |
| 260 | Breast Neoplasms, Male | 5.7% |
| 261 | Neoplasm Micrometastasis | 5.7% |
| 262 | Triple Negative Breast Neoplasms | 5.7% |
| 263 | Mastocytoma | 5.7% |
| 264 | Mastocytosis, Systemic | 5.7% |
| 265 | granulosa cell tumor | 5.7% |
| 266 | Carcinoma, Ovarian Epithelial | 5.7% |
| 267 | Esophageal Neoplasms | 5.7% |
| 268 | Gastrinoma | 5.6% |
| 269 | Glucagonoma | 5.6% |
| 270 | Limbic Encephalitis | 5.6% |
| 271 | Thyroid Nodule | 5.5% |
| 272 | Waldenstrom Macroglobulinemia | 5.3% |
| 273 | Multiple Myeloma | 5.3% |
| 274 | Leydig Cell Tumor | 5.2% |
| 275 | Adrenocortical carcinoma | 5.1% |
| 276 | Lambert-Eaton Myasthenic Syndrome | 5% |
| 277 | Testicular Neoplasms | 5% |
| 278 | Leukemia L1210 | 4.9% |
| 279 | Adrenal Gland Neoplasms | 4.8% |
| 280 | Gastrointestinal Neoplasms | 4.8% |
| 281 | Genital Neoplasms, Male | 4.8% |
| 282 | Liver neoplasms | 4.8% |
| 283 | Uveal Neoplasms | 4.8% |
| 284 | Urologic Neoplasms | 4.7% |
| 285 | Sebaceous Gland Neoplasms | 4.6% |
| 286 | Spinal Neoplasms | 4.6% |
| 287 | Bone Marrow Neoplasms | 4.6% |
| 288 | Polycystic Ovary Syndrome | 4.6% |
| 289 | Lymphoma, T-Cell, Cutaneous | 4.5% |
| 290 | Lymphoma, AIDS-Related | 4.5% |
| 291 | Enteropathy-Associated T-Cell Lymphoma | 4.5% |
| 292 | Primary Effusion Lymphoma | 4.5% |
| 293 | Nasopharyngeal carcinoma | 4.5% |
| 294 | Denys-Drash Syndrome | 4.5% |
| 295 | Opsoclonus-Myoclonus Syndrome | 4.4% |
| 296 | Renal Cell Carcinoma | 4.4% |
| 297 | Papillary Renal Cell Carcinoma | 4.4% |
| 298 | Carcinoma, Endometrioid | 4.2% |
| 299 | Meningeal Neoplasms | 4.1% |
| 300 | Dupuytren Contracture | 4% |
| 301 | Myelitis, Transverse | 3.9% |
| 302 | Urticaria Pigmentosa | 3.9% |
| 303 | Mycosis Fungoides | 3.8% |
| 304 | Lymphomatoid Papulosis | 3.8% |
| 305 | Plasmablastic lymphoma | 3.8% |
| 306 | Nose Neoplasms | 3.8% |
| 307 | Xeroderma Pigmentosum | 3.7% |
| 308 | Palatal Neoplasms | 3.7% |
| 309 | Ear Neoplasms | 3.4% |
| 310 | Eyelid Neoplasms | 3.4% |
| 311 | Lung Neoplasms | 3.4% |
| 312 | Pleural Neoplasms | 3.4% |
| 313 | Pituitary Adenoma | 3.4% |
| 314 | Pituitary Neoplasms | 3.4% |
| 315 | ovarian neoplasm | 3.3% |
| 316 | Cell Transformation, Viral | 3.3% |
| 317 | Brain Neoplasms | 3.3% |
| 318 | Salivary Gland Neoplasms | 3.3% |
| 319 | Spinal Cord Neoplasms | 3.3% |
| 320 | Tongue Neoplasms | 3.3% |
| 321 | Uterine Neoplasms | 3.2% |
| 322 | Vaginal Neoplasms | 3.2% |
| 323 | Vulvar Neoplasms | 3.2% |
| 324 | Uterine Cancer | 3.2% |
| 325 | Meningeal Carcinomatosis | 3.2% |
| 326 | Fallopian Tube Neoplasms | 3.2% |
| 327 | Burkitt Lymphoma | 3.2% |
| 328 | Pharyngeal Neoplasms | 2.8% |
| 329 | Central Nervous System Cysts | 2.8% |
| 330 | Sezary Syndrome | 2.8% |
| 331 | Bile Duct Neoplasms | 2.7% |
| 332 | gallbladder neoplasm | 2.7% |
| 333 | Intestinal Neoplasms | 2.7% |
| 334 | Penile Neoplasms | 2.7% |
| 335 | Prostatic Neoplasms | 2.7% |
| 336 | Stomach Neoplasms | 2.7% |
| 337 | Polycythemia Vera | 2.7% |
| 338 | Bronchial Neoplasms | 2.7% |
| 339 | Multiple Pulmonary Nodules | 2.6% |
| 340 | Supratentorial Neoplasms | 2.6% |
| 341 | Endometrial Neoplasms | 2.6% |
| 342 | Zollinger-Ellison syndrome | 2.6% |
| 343 | Laryngeal neoplasm | 2.5% |
| 344 | Bladder Neoplasm | 2.3% |
| 345 | Kidney Neoplasm | 2.3% |
| 346 | Ureteral Neoplasms | 2.3% |
| 347 | Urethral Neoplasms | 2.3% |
| 348 | Brain Stem Neoplasms | 2.2% |
| 349 | Hypopharyngeal Neoplasms | 2.2% |
| 350 | Pleural Effusion, Malignant | 2.2% |
| 351 | Hypopharyngeal Cancer | 2.2% |
| 352 | Parotid Neoplasms | 2.2% |
| 353 | Prostatic Neoplasms, Castration-Resistant | 2.2% |
| 354 | Nelson Syndrome | 2.1% |
| 355 | Choroid Plexus Papilloma | 2.1% |
| 356 | Tonsillar Neoplasms | 1.9% |
| 357 | Cerebellar Neoplasms | 1.9% |
| 358 | Cecal Neoplasms | 1.8% |
| 359 | Duodenal Neoplasms | 1.8% |
| 360 | Nasopharyngeal Neoplasms | 1.6% |
| 361 | Colorectal Neoplasms | 1.6% |
| 362 | Radicular Cyst | 1.6% |
| 363 | Appendiceal Neoplasms | 1.6% |
| 364 | Colonic Neoplasms | 1.6% |
| 365 | Rectal Neoplasms | 1.6% |
| 366 | Paranasal Sinus Neoplasms | 1.5% |
| 367 | Anus Neoplasms | 1.3% |
| 368 | Sigmoid Neoplasms | 1.3% |
| 369 | Maxillary Sinus Neoplasms | 1.3% |